Hiroshi Iijima

Dr. Hiroshi Iijima

orcid

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 1988 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JZJanusz. Zabrocki
Janusz. Zabrocki
GSG. David. Smith
G. David. Smith
JDJames B. Dunbar
James B. Dunbar
HIHiroshi Iijima
Hiroshi Iijima
GMGarland R. Marshall
Garland R. Marshall

29 August 2000 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
NBNicolas Burdin
Nicolas Burdin
LBLaurent Brossay
Laurent Brossay
MDMassimo Degano
Massimo Degano
HIHiroshi Iijima
Hiroshi Iijima
MGMing Gui
Ming Gui
MKMitchell Kronenberg
Mitchell Kronenberg
The structural basis for the T cell response to glycolipid antigens (Ags) remains poorly understood. T lymphocytes autoreactive for mouse CD1 (mCD1.1) or reactive for the glycosphingolipid αgalactosylceramide (α-GalCer) presented by mCD1.1 have been described previously. In this paper it is shown that mutations at the top of the α helices and in the bottom of the Ag-binding groove can disrupt both mCD1.1 autoreactivity and α-GalCer recognition. The locations of the positions that affect T cell responses indicate that recognition of mCD1.1 is not likely to be unconventional or superantigen-like. Furthermore, the effects of the bottom of the pocket mutation suggest that the autoreactive response could require an autologous ligand, and they indicate that α-GalCer binds to the groove of mCD1.1, most likely with the shorter 18-carbon hydrophobic chain in the A′ pocket. Natural killer T cell hybridomas with identical T cell antigen receptor (TCR) α chains and different β chains respond differently to α-GalCer presented by mCD1.1 mutants. This finding indicates a role for TCR β in defining natural killer T cell specificity, despite the more restricted diversity of the α chains in these cells. Overall, the data are consistent with a mode of lipoglycan recognition similar to that proposed for glycopeptides, in which the TCR α and β chains survey a surface composed of both mCD1.1 and the carbohydrate portion of α-GalCer.

7 April 2004 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
ATAtsuya Takami
Atsuya Takami
MIMasayuki Iwakubo
Masayuki Iwakubo
YOYuji Okada
Yuji Okada
TKTakehisa Kawata
Takehisa Kawata
HOHideharu Odai
Hideharu Odai
HIHiroshi Iijima
Hiroshi Iijima

1 January 1987 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Closed access
PDF file
HIHiroshi Iijima
Hiroshi Iijima
JDJames B. Dunbar
James B. Dunbar
GMGarland R. Marshall
Garland R. Marshall

1 July 2001 in International Immunology
Verified
Journal Article
Open access
PDF file
NKNoriaki Kamada
Noriaki Kamada
HIHiroshi Iijima
Hiroshi Iijima
KKKaname Kimura
Kaname Kimura
MHMichishige Harada
Michishige Harada
ESEiko Shimizu
Eiko Shimizu
MTMasaru Taniguchi
Masaru Taniguchi
A novel lymphocyte, NKT cells bearing an invariant Vα14 antigen receptor, specifically recognizes α-galactosylceramide (α-GalCer) exclusively presented by mouse CD1d (mCD1d). However, the precise molecular interaction remains unclear. For the basis of functional analyses, a docking model of α-GalCer with the crystal structure of mCD1d was constructed. Possible residues involved in the α-GalCer–mCD1d interaction were found to be Arg79, Glu83 and Asp80 for carbohydrate recognition, and Asp153 for interaction with the amide group on the fatty acyl chain. The α-GalCer-presenting ability of various transfectants expressing mutant mCD1d was completely abrogated if a single amino acid mutation was induced at positions 79, 80, 83 or 153, suggesting that the polar amino acids above the F′ pocket are crucial for α-GalCer presentation to activate Vα14 NKT cells. The possibility that Glu83 is a contact site for the NKT cell receptor is also discussed.

1 January 2011 in Biological and Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
TTTomoko Takamiya
Tomoko Takamiya
PWPheravut Wongsawad
Pheravut Wongsawad
NTNatsuko Tajima
Natsuko Tajima
NSNao Shioda
Nao Shioda
JLJun Feng Lu
Jun Feng Lu
TYTomohisa Yukawa
Tomohisa Yukawa
Stems of genus Dendrobium (Orchidaceae) have been traditionally used as an herbal medicine (Dendrobii Herba) in Eastern Asia. Although demand for Dendrobium is increasing rapidly, wild resources are decreasing due to over-collection. This study aimed to identify plant sources of Dendrobii Herba on the market based on sequences of the internal transcribed spacer (ITS) regions of nuclear ribosomal DNA. We constructed an ITS1-5.8S-ITS2 sequence database of 196 Dendrobium species, and the database was employed to identify 21 herbal samples. We found that 13 Dendrobium species (D. catenatum, D. cucullatum, D. denudans, D. devonianum, D. eriiflorum, D. hancockii, D. linawianum, D. lituiflorum, D. loddigesii, D. polyanthum, D. primulinum, D. regium, and D. transparens) were possibly used as plant sources of Dendrobii Herba, and unidentified species allied to D. denudans, D. eriiflorum, D. gregulus, or D. hemimelanoglossum were also used as sources. Furthermore, it is clear that D. catenatum is one of the most important sources of Dendrobii Herba (5 out of 21 samples).